A practical reference on Stability: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-06-14 and is reviewed periodically as new material appears.
Stability of NMN depends on physical form, temperature, moisture, light, and pH. The solid compound is generally more stable than aqueous solutions, which can degrade over time, especially when warm or exposed to extreme pH. Recommended laboratory storage is typically desiccated at −20 °C or below, protected from light, with containers sealed to limit moisture uptake. In solution, degradation products may include nicotinamide and related ribosides, and the rate varies with buffer composition and concentration. Analytical laboratories often prepare fresh solutions and validate stability for each method.
Quality control for NMN materials usually covers identity, assay purity, residual solvents, heavy metals, microbial limits, and moisture content. Certificates of analysis from suppliers may report high-performance liquid chromatography purity, mass spectrometry identity, and elemental impurity testing. Regulatory treatment differs by country: NMN is not an approved drug, and its status as a dietary supplement ingredient or novel food has been debated. Some authorities have restricted sales pending safety and regulatory review, while others allow it under specific categories. Buyers should verify documentation rather than rely on label claims.
Nicotinamide mononucleotide is usually handled as a dry powder because moisture can promote hydrolysis and shorten shelf life. Recommended storage conditions often include a desiccated container at minus twenty degrees Celsius or colder, with protection from light. Aqueous solutions are less stable than solid material and may degrade faster at ambient temperature or neutral pH. Repeated freeze-thaw cycles can introduce variability, so aliquoting is common in laboratory settings. These practices reflect general nucleotide chemistry rather than a single universal protocol.
Analytical laboratories identify and quantify NMN using several complementary techniques. High-performance liquid chromatography with ultraviolet detection is widely used for purity and assay work. Liquid chromatography coupled to mass spectrometry provides greater sensitivity and is common for biological matrices. Nuclear magnetic resonance spectroscopy supports structural confirmation and can distinguish related nucleotides. Accurate measurement depends on reference standards, validated methods, and careful sample preparation, especially because NMN can convert to related compounds under some conditions.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | −20 °C or below | Desiccated; amber container |
| Water solubility | Soluble | Polar; solution stability varies |
| Appearance | White to off-white powder | May be hygroscopic |
| Common analytical method | LC-MS/MS | Isotope-labeled internal standard often used |
| Common synonyms | NMN; β-nicotinamide mononucleotide | β form is commonly studied |
Regulatory treatment varies by country. In the United States, NMN has been marketed as a dietary supplement, but the Food and Drug Administration has stated that it is excluded from the dietary supplement definition because it was authorized for investigation as a new drug before being marketed as a supplement. Other jurisdictions may treat it as a novel food, a supplement, or an unapproved drug ingredient. Import and sale rules can therefore differ substantially.
Quality control for NMN focuses on identity, purity, residual solvents, heavy metals, and microbial limits. Because the molecule can absorb water, moisture content and packaging are relevant to shelf life. Suppliers may provide certificates of analysis, but independent verification is often needed for research or commercial use. The long-term stability of different crystal forms, salt forms, and formulations is not fully characterized in the public literature. Some degradation products and their effects on product performance remain open questions.
As a commercial ingredient, nicotinamide mononucleotide is commonly supplied as a powder or capsule. Its stability depends on temperature, moisture, pH, and light exposure. Hydrolytic and thermal degradation can increase over time, so manufacturers and laboratories often store material cold and dry. Purity is typically assessed with chromatographic methods, and identity can be confirmed by mass spectrometry. Published stability data for specific finished products remain limited. More data would help define shelf life under real-world conditions.
Analytical measurement of NMN typically uses reversed-phase high-performance liquid chromatography with ultraviolet detection near 260 nm. Mass spectrometry, often coupled to liquid chromatography, provides sensitive quantification and confirmatory identification in biological matrices. Nuclear magnetic resonance spectroscopy is used to verify molecular structure and distinguish related nucleotides. Because NMN is polar and poorly retained on conventional reversed-phase columns, ion-pairing reagents or hydrophilic interaction chromatography are sometimes employed. Reported purity values depend on the chosen method, calibration standard, and whether related substances are resolved.
Stability studies indicate that NMN is sensitive to heat, light, and pH extremes. In aqueous solution, hydrolysis can cleave the phosphate linkage or convert NMN to related nicotinamide derivatives, with degradation accelerating at elevated temperatures and alkaline conditions. Solid material is generally more stable when kept dry and cold, and research-grade supplies are often stored at minus twenty degrees Celsius or lower, protected from light and moisture. Repeated freeze-thaw cycles of solutions can promote degradation, so aliquoting is a common laboratory practice. The exact shelf life depends on purity, counterion, packaging, and storage history.
Quality control for NMN focuses on identity, purity, and the absence of harmful contaminants. Certificates of analysis may report high-performance liquid chromatography purity, mass spectrometry identity, residual solvents, heavy metals, and microbial limits, depending on grade and intended use. Because NMN can exist as different isomers, salts, or hydrates, specification sheets should state the exact form being tested. There is no single globally harmonized purity standard for NMN products. Open questions include which degradation products are most relevant under real-world storage and how analytical results from different laboratories can be compared reliably.
Common laboratory methods for NMN include high-performance liquid chromatography with ultraviolet detection, liquid chromatography coupled to mass spectrometry, and nuclear magnetic resonance spectroscopy. Because the nicotinamide ring absorbs ultraviolet light, HPLC-UV at wavelengths near 260 nm can be used for purity assessment. LC-MS and LC-MS/MS provide greater sensitivity and are often applied to biological samples. Identification typically relies on matching retention time, mass-to-charge ratio, and fragmentation pattern to a reference standard.
NMN is generally handled as a hygroscopic and light-sensitive solid in laboratory settings. Recommended storage is typically at -20°C or below, often under desiccation and protected from light. Aqueous solutions are less stable than the solid and may degrade through hydrolysis or other pathways, so fresh preparation is common for analytical work. Repeated freeze-thaw cycles can reduce sample integrity. Stability depends on pH, temperature, buffer composition, and the presence of metal ions, so specific shelf-life values should be determined experimentally rather than assumed.
Quality control for NMN samples often includes purity determination by HPLC, identity confirmation by mass spectrometry or NMR, and water content measurement by Karl Fischer titration. Certificates of analysis may report residual solvents, heavy metals, and microbial limits depending on the intended use. Purity values are method-dependent, so a stated percentage should be interpreted alongside the analytical procedure and detection wavelength. Reference standards help ensure that retention times and spectral data are comparable across laboratories. Researchers increasingly request independent verification because supply chains for specialty chemicals can vary in documentation.
25 May – Deputy Prime Minister Angela Rayner refuses to confirm whether the government will remove the two-child benefit cap in the 2025 budget. Nigel Farage says that Reform UK would scrap the two-child benefit cap, and restore winter fuel payments to pensioners, if elected. Labour's renationalisation of the UK's railways begins as the train operator South Western Railway is taken into public ownership. 26 May – King Charles III and Queen Camilla begin a two day visit to Canada, where the King will deliver a Speech from the throne in the Canadian Parliament, the first such speech in the country for 50 years. 27 May – Charles III addresses the opening session of the 45th Canadian Parliament, and receives a standing ovation from Canadian MPs following a speech in support of Canada staying "strong and free". Nigel Farage says that a future Reform UK government would introduce generous tax breaks for married couples to make it easier for them to have children, and scrap the two-child benefit cap. 29 May – The UK government reveals its plans for overhauling pension investment funds to create models similar to those in Australia and Canada; the plans include the creation of £25bn "megafunds" which will be instructed to make a portion of their investments locally to help fuel economic growth. In a speech attacking Reform policy, Starmer accuses Farage of "fantasy economics" and says his unfunded tax cuts would "crash the economy" like Liz Truss.
The AGA does not recommend extensive pre-procedural testing, including repeated measurements of PT/INR or platelet count, before patients with stable cirrhosis undergo common gastrointestinal procedures. Nor do they suggest the routine use of blood products, such as platelets, for bleeding prevention. Cirrhosis is stable when there are no changes in baseline abnormalities of coagulation lab values. For patients with stable cirrhosis and low platelet count undergoing common low-risk procedures, the AGA does not recommend the routine use of thrombopoietin receptor agonists for bleeding prevention. In hospitalized patients who meet standard guidelines for clot prevention, the AGA suggests standard prevention. The AGA does not recommend routine screening for portal vein thrombosis. If there is a portal vein thrombosis, the AGA suggests treatment by anticoagulation. In the case of cirrhosis with atrial fibrillation, the AGA recommends using anticoagulation over no anticoagulation.
=== Applied research === Ben-Tal has participated in research addressing biological systems of medical and security significance. His work has included computational analysis of membrane transport proteins and studies related to molecular mechanisms underlying disease and drug discovery. In collaboration with researchers from Turkey and Israel, he co-led a NATO Science for Peace and Security Programme project on the MntABC transporter of Bacillus anthracis. The project investigated the structure and functional dynamics of the transporter and sought potential compounds capable of inhibiting its activity. Ben-Tal, Türkan Haliloğlu, and Oded Lewinson were the project's co-directors. The project received the 2018 NATO SPS Partnership Prize in the field of chemical, biological, radiological and nuclear defence, with the award presented at NATO headquarters in November 2018.
Sources: en.wikipedia.org
== History == Acetone peroxide (specifically, triacetone triperoxide) was discovered in 1895 by a German chemist, Richard Wolffenstein. Wolffenstein combined acetone and hydrogen peroxide. Then he allowed the mixture to stand for a week at room temperature, during which time a small quantity of crystals precipitated, which had a melting point of 97 °C (207 °F). In 1899, Adolf von Baeyer and Victor Villiger described the first synthesis of the dimer and described use of acids for the synthesis of both peroxides. Baeyer and Villiger prepared the dimer by combining potassium persulfate in diethyl ether with acetone, under cooling. After separating the ether layer, the product was purified and found to melt at 132–133 °C (270–271 °F). They found that the trimer could be prepared by adding hydrochloric acid to a chilled mixture of acetone and hydrogen peroxide. By using the depression of freezing points to determine the molecular weights of the compounds, they also determined that the form of acetone peroxide that they had prepared via potassium persulfate was a dimer, whereas the acetone peroxide that had been prepared via hydrochloric acid was a trimer, like Wolffenstein's compound. Work on this methodology and on the various products obtained, was further investigated in the mid-20th century by Milas and Golubović.
=== Inhibin === Quantification of inhibin A is part of the prenatal quad screen that can be administered during pregnancy at a gestational age of 16–18 weeks. An elevated inhibin A (along with an increased beta-hCG, decreased AFP, and a decreased estriol) is suggestive of the presence of a fetus with Down syndrome. As a screening test, abnormal quad screen test results need to be followed up with more definitive tests. It also has been used as a marker for ovarian cancer. Inhibin B may be used as a marker of spermatogenesis function and male infertility. The mean serum inhibin B level is significantly higher among fertile men (approximately 140 pg/mL) than in infertile men (approximately 80 pg/mL). In men with azoospermia, a positive test for inhibin B slightly raises the chances for successfully achieving pregnancy through testicular sperm extraction (TESE), although the association is not very substantial, having a sensitivity of 0.65 (95% confidence interval [CI]: 0.56–0.74) and a specificity of 0.83 (CI: 0.64–0.93) for prediction the presence of sperm in the testes in non-obstructive azoospermia.
Confirmatory testing: compounds that were found active against the selected target are re-tested using the same assay conditions used during the HTS to make sure that the activity is reproducible. Dose response curve: the compound is tested over a range of concentrations to determine the concentration that results in half maximal binding or activity (IC50 or EC50 value respectively). Orthogonal testing: confirmed hits are assayed using a different assay which is usually closer to the target physiological condition or using a different technology. Secondary screening: confirmed hits are tested in a functional cellular assay to determine efficacy. Synthetic tractability: medicinal chemists evaluate compounds according to their synthesis feasibility and other parameters such as up-scaling or cost of goods. Biophysical testing: nuclear magnetic resonance (NMR), isothermal titration calorimetry (ITC), dynamic light scattering (DLS), surface plasmon resonance (SPR), dual polarisation interferometry (DPI), microscale thermophoresis (MST) are commonly used to assess whether the compound binds effectively to the target, the kinetics, thermodynamics, and stoichiometry of binding, any associated conformational change and to rule out promiscuous binding. Hit ranking and clustering: Confirmed hit compounds are then ranked according to the various hit confirmation experiments. Freedom to operate evaluation: hit structures are checked in specialized databases to determine if they are patentable.
== History == Molecular engineering was first mentioned in the research literature in 1956 by Arthur R. von Hippel, who defined it as "… a new mode of thinking about engineering problems. Instead of taking prefabricated materials and trying to devise engineering applications consistent with their macroscopic properties, one builds materials from their atoms and molecules for the purpose at hand." This concept was echoed in Richard Feynman's seminal 1959 lecture There's Plenty of Room at the Bottom, which is widely regarded as giving birth to some of the fundamental ideas of the field of nanotechnology. In spite of the early introduction of these concepts, it was not until the mid-1980s with the publication of Engines of Creation: The Coming Era of Nanotechnology by Drexler that the modern concepts of nano and molecular-scale science began to grow in the public consciousness. The discovery of electrically conductive properties in polyacetylene by Alan J. Heeger in 1977 effectively opened the field of organic electronics, which has proved foundational for many molecular engineering efforts. Design and optimization of these materials has led to a number of innovations including organic light-emitting diodes and flexible solar cells.
Sources: en.wikipedia.org
Barker was married to Dorothy Jo Gideon from 1945 until her death from lung cancer at age 57 in 1981. From 1983 until his death, Barker was in a long-term relationship with Nancy Burnet, a self-described "radical" animal rights activist nearly 20 years younger than Barker. By mutual decision, Barker and Burnet were never married and lived in separate residences throughout their relationship. Barker had no children with either woman, stating that he had seen friends who had poor relationships with their children and felt like he was too busy to properly raise a child; as of 2007, Barker stated that he had no regrets about his decision. During the early years of his relationship with Burnet, Barker also had a sexual relationship with Dian Parkinson, a model on The Price Is Right; other models on the program noted that the relationship was at one point close enough that there was a realistic chance of the two marrying. Barker and Parkinson's relationship ended acrimoniously along with Parkinson's tenure on the program in 1993. From the late 2000s onward, Burnet described the relationship as a platonic friendship, even as Barker had become more interested in remarrying; she recalled a 2011 incident where Barker drafted a prenuptial agreement for Burnet's lawyer to review and revise as she felt fit, which she refused. Burnet managed Barker's health and diet in retirement.
== Iron-60 == Iron-60 has a half-life of 2.62 million years, but was thought until 2009 to have a half-life of 1.5 million years. It undergoes beta decay to 60Co, which then decays with the much shorter half-life of about 5 years to stable 60Ni. In phases of the meteorites Semarkona and Chervony Kut, a correlation between the excess concentration of 60Ni, the granddaughter isotope of 60Fe, and the abundance of the stable iron isotopes could be found, which is evidence for the existence of 60Fe at the time of formation of the Solar System. Depending on its original abundance, the energy from the decay of 60Fe may have been significant, along with that of 26Al, to the remelting and differentiation of asteroids and planetesimals after their formation. These nickel abundances in extraterrestrial materials may also provide further insight into the origin of the Solar System and its early history. Live (interstellar) iron-60 was first identified in deep sea sediments in 1999. These are deep sea ferromanganese crusts, which are constantly growing, aggregating iron, manganese, and other elements. Iron-60 has been found in fossilized bacteria in sea floor sediments. In 2019, researchers found 60Fe in Antarctica. Iron-60 shows two peaks in deep sea sediments, the first 1.7–3.2 million years ago and the second 6.5–8.7 million years ago. The peaks are related to the passage of the Solar System through the Local Bubble and likely the Orion–Eridanus Superbubble. These superbubbles were created by multiple supernovae. Traces of iron-60 have also been found in lunar samples.
==== Betaferon (interferon beta-1b) ==== Closely related to interferon beta-1a is interferon beta-1b, which is also indicated for MS, but is formulated with a different dose and administered with a different frequency. Each drug has a different safety/efficacy profile. Interferon beta-1b is marketed only by Bayer in the US as Betaseron, and outside the US as Betaferon.
Sources: en.wikipedia.org
Liquid chromatography with tandem mass spectrometry is common because it can quantify low levels of NMN in complex samples. High-performance liquid chromatography with ultraviolet detection is used for simpler purity checks. Nuclear magnetic resonance can confirm identity and detect some impurities.
Solid NMN is typically kept desiccated at −20 °C or below and protected from light. Sealed containers reduce moisture exposure, which can promote degradation. Aqueous solutions are generally less stable and are often prepared fresh.
Important checks include identity confirmation, purity assay, moisture, heavy metals, residual solvents, and microbial contamination. A certificate of analysis should list the methods used and the specification limits. Independent testing can help verify supplier claims.
Solid NMN is often kept cool, dry, and protected from light. Long-term storage may use temperatures at or below minus twenty degrees Celsius. Moisture and repeated temperature changes should be avoided.